Funding has now been discontinued for the National Clinical Evidence Taskforce and the COVID-19 guidelines as of 30 June 2023.
These guidelines are no longer continually updated but will remain online until the guidance becomes inaccurate and/or no longer reflects the evidence or recommended practice.
As of 31 July 2023, the National Clinical Evidence Taskforce is no longer funded. The COVID-19 and MPX guidelines are still accessible online, but are not currently being updated.
For more information and the latest developments in Australian living evidence visit livingevidence.org.au
Evidence-based clinical COVID-19 guidelines updated with the latest research
We will revise and add recommendations each week as our evidence teams and expert panels identify priority clinical questions and synthesise new research.
Flowcharts incorporating living guideline recommendations and guidance issued or endorsed by Taskforce members
Continuously reviewing new evidence to update recommendations and address new priority questions
Your views help us to identify and prioritise questions to include in the living guideline.
Submit your questions here
Subscribe here to receive regular updates from the Taskforce
Cochrane’s COVID-19 Study Register is a freely-available, continually-updated, annotated reference collection of human studies on COVID-19, including interventional, observational, diagnostic, prognostic, epidemiological, and economic designs.
The ANZCTR is an online registry of clinical trials being undertaken in Australia, New Zealand and elsewhere. A list of coronavirus/COVID-19 studies currently recruiting in Australia is available here.
The COVID-19-COS project is an international initiative bringing together patients, the public and health professionals to identify, prioritise and agree on the most important outcomes for research in COVID-19.
